Endometriosis Market Size, Segmentation and Future Forecasts to 2026

1. Endometriosis Market To Reach USD 2.42 Billion By 2026 www.reportsanddata.com sales@reportsanddata.com

2. Market Summary Increasing awareness about women's health, increasing occurrence rate of the condition, the rising focus on clinical trials are some of the factors boosting the endometriosis market. Market Size – USD 1.93 Billion in 2018, Market Growth - CAGR of 2.8%, Market Trends –The increasing focus on clinical trial.

3. Our Approach Market Summary The Global endometriosis market is forecast to reach USD 2.42 Billion by 2026, according to a new report by Reports and Data. Endometriosis is the resultant of the growth of endometrial tissue on bowel, ovaries, and tissues lining the pelvis. The hormonal changes associated with the menstrual cycle impacts the misplaced endometrial tissue that results in the area to become inflamed that causes pain. It implies that the tissue will thicken, grow, and break down. With time, the tissue that broken down has nowhere to go and becomes trapped in pelvis. The market is projected to witness considerable growth during the forecast period. One of the mentionable factors in this regards being, the increasing occurrence rate of the condition. It has turned out to be a common gynecological condition, affecting approximately 10% of women. Treatment for the disease is dependent on the severity of the disease, symptoms, and if the care user wishes to have children. The condition is treatable with surgery, medication, or both. Medication is usually tried first when pain is the primary problem. Medications that are prescribed to treat the condition include pain relievers like nonsteroidal anti-inflammatory drugs (NSAIDs), and hormonal medications, including gonadotropin-releasing hormone agonists and birth control pills, progestin. Key participants include Johnson & Johnson Services Inc., Bayer AG, Neurocrine Biosciences Inc., Meditrina Pharmaceuticals Inc., AbbVie Inc., Astellas Pharma Inc., AstraZeneca Plc, Evotec AG, Debiopharm Group and Teva Pharmaceutical Industries Ltd. To Get Sample Copy of Report visit: https://www.reportsanddata.com/sample-enquiry-form/2553

4. Our Approach Market Summary For the purpose of this report, Reports and Data have segmented the global endometriosis market based on Surgery Type, Drug Type, End-Users, and region: Surgery Type Outlook (Revenue, USD Billion; 2016-2026) Laparoscopy Laparotomy Pelvic nerves surgery Drug Type Outlook (Revenue, USD Billion; 2016-2026) NSAID’s Gonadotropins Releasing Hormone Agonists Progestin Oral Contraceptive Pills End-Users Type Outlook (Revenue, USD Billion; 2016-2026) Hospital Pharmacies Drugstores E-commerce Any Query or Discount? Ask our Expert @ https://www.reportsanddata.com/discount-enquiry-form/2553

5. Our Approach Market Summary Further key findings from the report suggest The endometriosis market held a market share of USD 1.93 Billion in the year 2018 and forecasted to grow at a rate of 2.8% during the forecast period. In regards to Drug Type, the NSAID’s segment generated the highest revenue of USD 0.58 Billion in 2018, with a growth rate of 2.9% during the forecast period. The effectiveness of the medicine in relieving pain caused by the condition, which are nonsteroidal anti-inflammatory drugs that work by discontinuing the release of prostaglandins that is one of the main chemicals resulting in the pain, contributes to the revenue generated by the NSAID’s segment. In context to Surgery Type, the Laparoscopy segment yielded the highest revenue of USD 0.87 Billion in 2018, with the fastest growth rate of 3.2% during the forecast period. The effectiveness of this surgery in accurately diagnosing endometriosis and even eliminate it in mild-moderate condition with just a small incision resulted in its increased demand and revenue generated by the In regards to the End-users, the Drugstores segment can be seen to occupy the largest market share of 30.2% in 2018, with the second-highest growth rate of 3.1% during the forecast period. The fact that in most cases of endometriosis, pain in the primary issue, in which medication is the first choice, has resulted in high dependency on drugstores for availing the prescribed medication, which contributes to the market share occupied by this segment. Read More @ https://www.reportsanddata.com/report-detail/endometriosis-market

6. Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Contact Us: John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com Our Approach About Us